Healthcare | Biotechnology | USA
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company is headquartered in Emery...
Market capitalization
$55.30B
Price to earnings Ratio (TTM)
0
Dividend yield (indicated)
0%
Basic EPS (TTM)
$-2.36
Net income (FY)
$-88.78B
Revenue (FY)
$25.21B